(MedPage Today) — Solutions are often elusive, says Skeptical Scalpel
Coalition of Healthcare Leaders Urges 6 Key Reforms
(MedPage Today) — Recommendations include increasing patient engagement, accelerating interoperability
Uncategorized
Publication Exclusive: Repositioning a dislocated IOL can be complicated but have good results
Despite our best efforts, complications happen during cataract surgery, and often it is not surgeon error, but rather weakness or irregularity in the tissue of the patient. When cataract surgery patients do not have a sufficient degree of capsular supp…
Uncategorized
STAAR Surgical, Aier Eye Hospital Group enter into strategic cooperation agreement
STAAR Surgical has entered into an agreement with Aier Eye Hospital Group, the largest refractive surgery provider in China, to provide STAAR’s CentraFLOW IOL as a primary and premium option for refractive eye treatment, according to a press release from STAAR. Hospital officials believe that the partnership with STAAR will result in a strong collaboration expected to include surgeon training, clinical studies, patient registries, local inventory, patient information both in person and through digital communications, and an ability to meet patient demand, Li Li, CEO of Aier Eye Hospital Group, said in the release.
Kellogg investigators develop new nanotechnology that has potential to kill tumor cells in the eye
Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell’s protective mechanism against itself — short-circuiting tumor cell metabolism and killing tumor cells.
Kellogg researchers develop new nanoparticle with potential to treat ocular cancer
Using nanoparticles to kill tumor cells inside the eye.Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell’s protective…